V-LAB Trademark

Trademark Overview

On Wednesday, December 13, 2023, a trademark application was filed for V-LAB with the United States Patent and Trademark Office. The USPTO has given the V-LAB trademark a serial number of 98311621. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 31, 2025. This trademark is owned by B&E Biomedical Inc.. The V-LAB trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit
v-lab

General Information

Serial Number98311621
Word MarkV-LAB
Filing DateWednesday, December 13, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkVETERINARY LAB
Goods and ServicesMedical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, December 13, 2023
Primary Code010
First Use Anywhere DateTuesday, June 20, 2023
First Use In Commerce DateTuesday, June 20, 2023

Trademark Owner History

Party NameB&E Biomedical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89141-7989

Trademark Events

Event DateEvent Description
Wednesday, December 13, 2023NEW APPLICATION ENTERED
Sunday, March 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION E-MAILED
Friday, July 12, 2024ASSIGNED TO EXAMINER
Monday, August 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Monday, July 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Thursday, November 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2024FINAL REFUSAL WRITTEN
Friday, September 6, 2024FINAL REFUSAL E-MAILED
Friday, September 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 24, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, November 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 21, 2024ASSIGNED TO LIE
Thursday, December 12, 2024CONTINUATION OF FINAL REFUSAL E-MAILED
Thursday, December 12, 2024ACTION CONTINUING A FINAL - COMPLETED
Thursday, December 12, 2024NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, March 31, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 31, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

blood medical processing software transmitting recording data unit sold therewith